FdaApplication
NDA 206041
Identifiers
- fda_app_no: NDA206041
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABS LTD |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE | ATAZANAVIR SULFATE; RITONAVIR; LAMIVUDINE; ZIDOVUDINE | 300MG;100MG;150MG;300MG | TABLET;ORAL |
1 product